PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs.
| Autor: | Weigelt, B1, Warne, P H1, Downward, J1 |
|---|---|
| Zdroj: | Oncogene. 7/21/2011, Vol. 30 Issue 29, p3222-3233. 12p. 1 Diagram, 1 Chart, 4 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|